Horizon Therapeutics Public Ltd Co

GEODE CAPITAL MANAGEMENT, LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

3,360,567

Value ($000)

388,303

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	388,303	0.0%	3,360,567	9/30/2023
2023 Q2	8/11/2023	336,556	0.0%	3,277,541	6/30/2023
2023 Q1	5/15/2023	346,484	0.0%	3,179,053	3/31/2023
2022 Q4	2/13/2023	349,392	0.0%	3,073,801	12/31/2022
2022 Q3	11/14/2022	186,730	0.0%	3,019,338	9/30/2022
2022 Q2	8/12/2022	238,644	0.0%	2,995,375	6/30/2022
2022 Q1	5/13/2022	316,533	0.0%	3,012,695	3/31/2022
2021 Q4	2/11/2022	312,637	0.0%	2,905,298	12/31/2021
2021 Q3	11/12/2021	307,873	0.0%	2,814,595	9/30/2021
2021 Q2	8/13/2021	263,189	0.0%	2,814,589	6/30/2021
2021 Q1	5/12/2021	248,636	0.0%	2,705,039	3/31/2021
2020 Q4	2/12/2021	191,113	0.0%	2,615,625	12/31/2020
2020 Q3	11/13/2020	182,272	0.0%	2,346,450	9/30/2020
2020 Q2	8/13/2020	123,905	0.0%	2,229,315	6/30/2020
2020 Q1	5/14/2020	65,579	0.0%	2,214,031	3/31/2020
2019 Q4	2/13/2020	76,847	0.0%	2,122,863	12/31/2019